Decrease in the incidence of mupirocin resistance among methicillin-resistant Staphylococcus aureus in carriers from an intensive care unit

被引:10
作者
Caierao, J
Berquó, L
Dias, C
d'Azevedo, PA
机构
[1] Fdn Fac Fed Ciencias Med Porto Alegre, BR-90050170 Porto Alegre, RS, Brazil
[2] Hosp Mae de Deus, Porto Alegre, RS, Brazil
关键词
D O I
10.1016/j.ajic.2005.08.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a serious nosocomial problem, globally distributed. Decolonization with mupirocin can be used to control its dissemination. Objective: To determine the incidence of mupirocin resistance among MRSA carriers from an intensive care unit. Methods: We obtained 2723 nasal swabs during 3 years. Resistance to methicillin and mupirocin were verified (agar diffusion and the E test) and confirmed by polymerase chain reaction (PCR) (mecA for methicillin; ReS-2 and mupA for mupirocin). Plasmid-curing procedure and pulsed-held gel electrophoresis (PFGE) were employed in isolates exhibiting high resistance to mupirocin (HR-Mup) and in other selected organisms. Results: The overall incidence of HR-Mup among MRSA carriers during the studied period was 4.84% (8/165); however, the incidence decreased from 13.04% (6/46) in the first year to 3.5% (2/57) in the second year and was 0% in the last year (P = .02). LR-Mup, in contrast, increased significantly (P = .01). Conclusion: Plasmid-curing procedure showed the plasmid location of genes responsible for HR-Mup. PFGE demonstrated that most MRSA, including the isolates with HR-Mup, were genetically related, The decline in HR-Mup may be attributable to the plasmid location of genes (ileS-2/mupA) and to the fact that all patients colonized with HR-Mup MRSA died or were discharged in a relatively short period of time.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 21 条
[1]  
[Anonymous], M100S12 NAT COMM CLI
[2]   Molecular characterization of resistance to mupirocin in methicillin-susceptible and -resistant isolates of Staphylococcus aureus from nasal samples [J].
Chaves, F ;
García-Martínez, J ;
de Miguel, S ;
Otero, JR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :822-824
[3]   Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998 [J].
Diekema, DJ ;
Pfaller, MA ;
Turnidge, J ;
Verhoef, J ;
Bell, J ;
Fluit, AC ;
Doern, GV ;
Jones, RN .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2000, 6 (03) :213-221
[4]  
DOSSANTOS KR, 1998, INFECT CONT HOSP EP, V19, P622
[5]   HIGH-LEVEL MUPIROCIN RESISTANCE IN STAPHYLOCOCCUS-AUREUS - EVIDENCE FOR 2 DISTINCT ISOLEUCYL-TRANSFER RNA-SYNTHETASES [J].
GILBART, J ;
PERRY, CR ;
SLOCOMBE, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) :32-38
[6]   Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA [J].
Girou, E ;
Pujade, G ;
Legrand, P ;
Cizeau, F ;
Brun-Buisson, C .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (03) :543-550
[7]  
*HOSP INF CONTR PR, 1996, AM J INFECT CONTROL, V24, P32
[8]   INHIBITION OF ISOLEUCYL-TRANSFER RIBONUCLEIC-ACID SYNTHETASE IN ESCHERICHIA-COLI BY PSEUDOMONIC ACID [J].
HUGHES, J ;
MELLOWS, G .
BIOCHEMICAL JOURNAL, 1978, 176 (01) :305-318
[9]   CHARACTERIZATION OF A CONJUGATIVE STAPHYLOCOCCAL MUPIROCIN RESISTANCE PLASMID [J].
MORTON, TM ;
JOHNSTON, JL ;
PATTERSON, J ;
ARCHER, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1272-1280
[10]  
Nunes ELD, 1999, DIAGN MICR INFEC DIS, V34, P77